The somatic and germline mutational landscape of HPV-negative oral cancer patients with a history of chewing tobacco and betel nut use
Preprint
Abstract
Head and neck cancer (HNC) is highly prevalent in South-Asia, driven by additional region-specific exposures such as chewing tobacco and betel nut. Despite therapeutic advances, five-year survival rate remains around 50-60%, underscoring urgent need to identify novel therapeutic targets and improve disease-free survival. This study was designed to identify both somatic and germline drivers contributing to HNC pathogenesis. Through whole-exome sequencing of 103 patients, we detected mutations in known HNC drivers (TP53, CDKN2A, NOTCH1) as well as novel hotspots in several genes, including TRIM48, MAP3K19, and CDC20. A recurrent hotspot mutation (p.A187T) in POLQ gene was identified in patients with high tumor mutation burden and was absent in both TCGA and ICGC cohorts. Among known hotspots, the MYC p.T73A mutation was highly prevalent, occurring in over 50% of patients. As MYC is considered an “undruggable” target, alternative strategies targeting upstream regulators such as BRD4 with specific inhibitors may hold promise for South-Asian HNSCC patients harboring the p.T73A mutation. Copy-number variation analysis further revealed EGFR amplification and TP73 deletion in the majority of patients, highlighting additional layers of genomic dysregulation. Comparative genomic analyses showed no recurrent mutations in epigenetic regulators (ARID2, EP300, KMT2B/MLL2, KMT2D/MLL4, NSD1, and TET1). We report p.S456L germline variant in SDHA consistently among South-Asian cohorts. Patients with p.S456L mutation were younger than those without it, reflecting typical epidemiological signature of a genetic variant that increases susceptibility. Systematic molecular characterization of recurrent mutations is required to elucidate mechanism of action of these variants and to find actionable therapeutic targets.Keywords
This publication has 49 references indexed in Scilit:
- Enhancing the detection of clinically relevant biomarkers in advanced uterine and tubo-ovarian carcinomas through genome-wide analysisPathology - Research and Practice, 2024
- Targeting the DNA Repair Enzyme Polymerase θ in Cancer TherapyTrends in Cancer, 2021
- Pathogenic Germline Variants in 10,389 Adult CancersCell, 2018
- TRIM48 Promotes ASK1 Activation and Cell Death through Ubiquitination-Dependent Degradation of the ASK1-Negative Regulator PRMT1Cell Reports, 2017
- Universal Patterns of Selection in Cancer and Somatic TissuesCell, 2017
- Genomic characterization of tobacco/nut chewing HPV-negative early stage tongue tumors identify MMP10 as a candidate to predict metastasesOral Oncology, 2017
- Implications of Genetic and Epigenetic Alterations of CDKN2A (p16 INK4a ) in CancerEBioMedicine, 2016
- MYC on the Path to CancerCell, 2012
- The Myc oncoprotein as a therapeutic target for human cancerSeminars in Cancer Biology, 2006
- Transcriptional inactivation of TP73 expression in oligodendroglial tumorsInternational Journal of Cancer, 2002